BT-11원지추출분말

MFDS recognition no.	2009-12
Approval route	Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)	11.0–300.0 mg/일
Approval holder	(주)바이오스타줄기세포기술연구원

Approved wording (Korean original)

성인의 기억력 개선을 도움을 줄 수 있음(생리활성기능 2등급)

Precautions (Korean original)

1) 과다섭취 시 구토, 설사, 메스꺼움 등의 위장관 장애가 나타날 수 있으며 위장장애가 있는 분은 섭취에 주의 2) 임산부, 수유 여성, 어린이는 섭취에 주의

the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.